Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $17.54 million. The enterprise value is $14.99 million.

Market Cap	17.54M
Enterprise Value	14.99M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDI has 36.32 million shares outstanding. The number of shares has increased by 374.79% in one year.

Current Share Class	34.52M
Shares Outstanding	36.32M
Shares Change (YoY)	+374.79%
Shares Change (QoQ)	+95.41%
Owned by Insiders (%)	3.80%
Owned by Institutions (%)	4.88%
Float	33.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.10
P/TBV Ratio	11.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 3.58.

Current Ratio	1.08
Quick Ratio	1.01
Debt / Equity	3.58
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-112.47%
Return on Invested Capital (ROIC)	-340.04%
Return on Capital Employed (ROCE)	-464.70%
Revenue Per Employee	n/a
Profits Per Employee	-$850,500
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $14,000 in taxes.

Income Tax	14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.70% in the last 52 weeks. The beta is 1.19, so CLDI's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-69.70%
50-Day Moving Average	0.73
200-Day Moving Average	1.24
Relative Strength Index (RSI)	39.50
Average Volume (20 Days)	387,216

Short Selling Information

The latest short interest is 171,127, so 0.47% of the outstanding shares have been sold short.

Short Interest	171,127
Short Previous Month	639,393
Short % of Shares Out	0.47%
Short % of Float	0.52%
Short Ratio (days to cover)	0.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.78M
Pretax Income	-29.96M
Net Income	-23.81M
EBITDA	-21.37M
EBIT	-21.78M
Earnings Per Share (EPS)	-$2.97

Balance Sheet

The company has $9.59 million in cash and $7.04 million in debt, giving a net cash position of $2.56 million or $0.07 per share.

Cash & Cash Equivalents	9.59M
Total Debt	7.04M
Net Cash	2.56M
Net Cash Per Share	$0.07
Equity (Book Value)	1.97M
Book Value Per Share	0.07
Working Capital	731,000

Cash Flow

In the last 12 months, operating cash flow was -$19.69 million and capital expenditures -$16,000, giving a free cash flow of -$19.71 million.

Operating Cash Flow	-19.69M
Capital Expenditures	-16,000
Free Cash Flow	-19.71M
FCF Per Share	-$0.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-374.79%
Shareholder Yield	n/a
Earnings Yield	-135.75%
FCF Yield	-112.35%

Analyst Forecast

The average price target for CLDI is $15.00, which is 3,005.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	3,005.59%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 15, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3